Predictive factors for long‐term responders of pemetrexed maintenance treatment in non‐small cell lung cancer

BACKGROUND: We determined the clinical characteristics and predictive factors of long‐term response to pemetrexed maintenance therapy as first‐line treatment for non‐small cell lung cancer (NSCLC). METHODS: A total of 950 advanced NSCLC patients received pemetrexed (500 mg/m(2)) plus cisplatin (60 m...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Joon‐Young, Park, Cheol‐Kyu, Choi, Yoo‐Duk, Oh, In‐Jae, Kim, Young‐Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449266/
https://www.ncbi.nlm.nih.gov/pubmed/30864258
http://dx.doi.org/10.1111/1759-7714.13033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449266/
https://www.ncbi.nlm.nih.gov/pubmed/30864258
http://dx.doi.org/10.1111/1759-7714.13033

Ejemplares similares